[Peritoneal tumor pathology - case no. 3 : peritoneal well-differentiated papillary mesothelioma]

MeSH terms

• Antineoplastic Agents, Phytogenic / therapeutic use
• Antineoplastic Combined Chemotherapy Protocols / administration & dosage
• Antineoplastic Combined Chemotherapy Protocols / therapeutic use
• Biomarkers, Tumor
• Camptothecin / administration & dosage
• Camptothecin / analogs & derivatives
• Carboplatin / administration & dosage
• Combined Modality Therapy
• Cystadenofibroma / drug therapy
• Cystadenofibroma / pathology
• Cystadenofibroma / surgery
• Diagnosis, Differential
• Female
• Fluorouracil / administration & dosage
• Humans
• Hyperthermia, Induced
• Infusions, Parenteral
• Irinotecan
• Leucovorin / administration & dosage
• Mesothelioma / drug therapy
• Mesothelioma / pathology*
• Mesothelioma / surgery
• Middle Aged
• Neoplasm Recurrence, Local / drug therapy
• Neoplasms, Second Primary / drug therapy
• Neoplasms, Second Primary / pathology*
• Neoplasms, Second Primary / surgery
• Organoplatinum Compounds / administration & dosage
• Ovarian Neoplasms / drug therapy
• Ovarian Neoplasms / pathology
• Ovarian Neoplasms / surgery
• Ovariectomy
• Oxaliplatin
• Paclitaxel / administration & dosage
• Pemetrexed / administration & dosage
• Peritoneal Neoplasms / drug therapy
• Peritoneal Neoplasms / pathology*
• Peritoneal Neoplasms / surgery